We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Join our healthcare community
Explore Macular Degeneration (AMD), a leading cause of vision loss impacting central vision. Learn about its dry and wet forms, risk factors, symptoms, and critical management options, including AREDS supplements and anti-VEGF injections. Discover how to protect your eyesight and adapt to living ...
Macular degeneration, often referred to as Age-related Macular Degeneration (AMD), is a leading cause of vision loss among people 50 and older. This chronic eye disease affects the macula, the central part of the retina responsible for sharp, detailed central vision. While it rarely leads to complete blindness, AMD can severely impair the ability to read, drive, recognize faces, and perform tasks that require fine vision, significantly impacting quality of life.
The macula is a small, specialized area at the center of the retina, a light-sensitive layer of tissue at the back of the eye. It is crucial for seeing fine details and colors, essential for tasks like reading, driving, and recognizing faces. Damage to the macula directly affects your central vision, leaving peripheral (side) vision generally unaffected.
There are two main forms of AMD:
While the exact cause of AMD is not fully understood, a combination of genetic and environmental factors is believed to play a role:
In its early stages, AMD may have no noticeable symptoms. As the disease progresses, common symptoms include:
Early detection is key to managing AMD. A comprehensive eye exam typically includes:
Currently, there is no cure for dry AMD. However, its progression can often be slowed:
Wet AMD often requires more aggressive treatment to prevent rapid vision loss:
While AMD cannot always be prevented, certain steps can reduce your risk and manage the condition:
Living with macular degeneration can be challenging, but many resources are available. Vision rehabilitation services, low vision specialists, and support groups can help individuals adapt to vision changes and maintain independence.
Dry AMD is more common and involves the slow breakdown of light-sensitive cells in the macula, often due to drusen deposits. Wet AMD is less common but more severe, characterized by abnormal, leaky blood vessel growth under the macula, leading to rapid vision loss.
There is currently no cure for macular degeneration. However, treatments for wet AMD can effectively manage the condition and prevent further vision loss, and supplements can slow the progression of dry AMD in some cases.
AREDS2 supplements are specifically recommended for people with intermediate AMD or advanced AMD in one eye. It's crucial to consult your ophthalmologist before starting any supplements, as they may not be beneficial for early AMD and could have risks for some individuals.
The frequency of anti-VEGF injections for wet AMD varies depending on the individual's response to treatment and the specific medication used. Initially, injections might be monthly, with the frequency potentially decreasing over time as the condition stabilizes. Your ophthalmologist will create a personalized treatment schedule.
The Amsler grid is a simple tool consisting of a grid of straight lines with a dot in the center. You look at the center dot with one eye at a time. If the lines appear wavy, broken, or distorted, it could indicate changes in your macula. Your doctor can provide an Amsler grid for regular self-monitoring at home.
Visit Hospital
Near You

Explore the stages of gum disease from gingivitis to advanced periodontitis. Learn about symptoms, systemic risks, deep cleaning treatments, and local expert care.
June 13, 2026

Learn about asthma, its triggers, diagnostic tests, and treatment plans. Find out how long-term control inhalers and local clinical care help manage your breathing.
June 13, 2026

Discover the primary types of pulmonary disease, what causes lung damage, warning symptoms, diagnosis, and expert respiratory management options.
June 13, 2026